Definitive Healthcare Corp (DH)

$4.44

+0.06

(+1.37%)▲

Market is closed - opens 7 PM, 16 Sep 2024

Performance

  • $4.35
    $4.49
    $4.44
    downward going graph

    2.03%

    Downside

    Day's Volatility :3.12%

    Upside

    1.11%

    downward going graph
  • $3.19
    $10.62
    $4.44
    downward going graph

    28.15%

    Downside

    52 Weeks Volatility :69.96%

    Upside

    58.19%

    downward going graph

Returns

PeriodDefinitive Healthcare CorpSector (Health Care)Index (Russel 2000)
3 Months
-21.0%
7.0%
0.0%
6 Months
-45.12%
7.0%
0.0%
1 Year
-46.31%
17.2%
0.0%
3 Years
-89.74%
18.0%
-20.0%

Highlights

Market Capitalization
513.0M
Book Value
$5.51
Earnings Per Share (EPS)
-3.5
Wall Street Target Price
5.72
Profit Margin
-156.66%
Operating Margin TTM
-4.78%
Return On Assets TTM
-0.83%
Return On Equity TTM
-49.62%
Revenue TTM
258.5M
Revenue Per Share TTM
2.22
Quarterly Revenue Growth YOY
4.6%
Gross Profit TTM
196.8M
EBITDA
27.9M
Diluted Eps TTM
-3.5
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.32
EPS Estimate Next Year
0.33
EPS Estimate Current Quarter
0.09
EPS Estimate Next Quarter
0.09

Analyst Recommendation

Buy
    57%Buy
    42%Hold
    0
    0%Sell
Based on 21 Wall street analysts offering stock ratings for Definitive Healthcare Corp(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
9
9
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 28.83%

Current $4.44
Target $5.72

Company Financials

FY19Y/Y Change
Revenue
85.5M
-
Net Income
-36.4M
-
Net Profit Margin
-42.57%
-
FY20Y/Y Change
Revenue
118.3M
↑ 38.38%
Net Income
-87.6M
↑ 140.8%
Net Profit Margin
-74.08%
↓ 31.51%
FY21Y/Y Change
Revenue
166.2M
↑ 40.43%
Net Income
-61.3M
↓ 30.11%
Net Profit Margin
-36.87%
↑ 37.21%
FY22Y/Y Change
Revenue
222.7M
↑ 34.0%
Net Income
-22.3M
↓ 63.67%
Net Profit Margin
-10.0%
↑ 26.87%
FY23Y/Y Change
Revenue
251.4M
↑ 12.92%
Net Income
-202.4M
↑ 809.4%
Net Profit Margin
-80.5%
↓ 70.5%
Q1 FY23Q/Q Change
Revenue
59.2M
↓ 2.31%
Net Income
-15.6M
↓ 331.63%
Net Profit Margin
-26.35%
↓ 37.46%
Q2 FY23Q/Q Change
Revenue
61.0M
↑ 2.97%
Net Income
-8.6M
↓ 45.09%
Net Profit Margin
-14.05%
↑ 12.3%
Q3 FY23Q/Q Change
Revenue
65.3M
↑ 7.17%
Net Income
-171.5M
↑ 1902.4%
Net Profit Margin
-262.57%
↓ 248.52%
Q4 FY23Q/Q Change
Revenue
65.9M
↑ 0.93%
Net Income
-10.2M
↓ 94.03%
Net Profit Margin
-15.52%
↑ 247.05%
Q1 FY24Q/Q Change
Revenue
63.5M
↓ 3.72%
Net Income
-9.5M
↓ 6.99%
Net Profit Margin
-14.99%
↑ 0.53%
Q2 FY24Q/Q Change
Revenue
63.7M
↑ 0.4%
Net Income
-213.6M
↑ 2144.54%
Net Profit Margin
-335.18%
↓ 320.19%
FY19Y/Y Change
Total Assets
1.7B
-
Total Liabilities
504.9M
-
FY20Y/Y Change
Total Assets
1.7B
↑ 1.41%
Total Liabilities
549.8M
↑ 8.89%
FY21Y/Y Change
Total Assets
2.1B
↑ 21.24%
Total Liabilities
612.7M
↑ 11.45%
FY22Y/Y Change
Total Assets
2.1B
↑ 0.24%
Total Liabilities
633.8M
↑ 3.43%
FY23Y/Y Change
Total Assets
1.8B
↓ 13.91%
Total Liabilities
626.7M
↓ 1.11%
Q1 FY23Q/Q Change
Total Assets
2.1B
↓ 0.27%
Total Liabilities
645.8M
↑ 1.9%
Q2 FY23Q/Q Change
Total Assets
2.1B
↓ 0.49%
Total Liabilities
649.4M
↑ 0.56%
Q3 FY23Q/Q Change
Total Assets
1.8B
↓ 13.56%
Total Liabilities
616.1M
↓ 5.13%
Q4 FY23Q/Q Change
Total Assets
1.8B
↑ 0.35%
Total Liabilities
626.7M
↑ 1.73%
Q1 FY24Q/Q Change
Total Assets
1.8B
↓ 0.86%
Total Liabilities
615.1M
↓ 1.85%
Q2 FY24Q/Q Change
Total Assets
1.4B
↓ 21.42%
Total Liabilities
536.1M
↓ 12.84%
FY19Y/Y Change
Operating Cash Flow
21.6M
-
Investing Cash Flow
-1.1B
-
Financing Cash Flow
1.1B
-
FY20Y/Y Change
Operating Cash Flow
23.2M
↑ 7.52%
Investing Cash Flow
-23.9M
↓ 97.91%
Financing Cash Flow
16.7M
↓ 98.52%
FY21Y/Y Change
Operating Cash Flow
25.2M
↑ 8.59%
Investing Cash Flow
-46.7M
↑ 95.84%
Financing Cash Flow
384.4M
↑ 2207.85%
FY22Y/Y Change
Operating Cash Flow
35.6M
↑ 41.12%
Investing Cash Flow
-248.9M
↑ 432.63%
Financing Cash Flow
-26.7M
↓ 106.95%
Q1 FY23Q/Q Change
Operating Cash Flow
15.0M
↓ 454.43%
Investing Cash Flow
-33.5M
↓ 50.7%
Financing Cash Flow
-3.5M
↓ 62.73%
Q2 FY23Q/Q Change
Operating Cash Flow
12.0M
↓ 19.52%
Investing Cash Flow
-33.5M
↑ 0.0%
Financing Cash Flow
-5.6M
↑ 59.74%

Technicals Summary

Sell

Neutral

Buy

Definitive Healthcare Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Definitive Healthcare Corp
Definitive Healthcare Corp
17.77%
-45.12%
-46.31%
-89.74%
-89.74%
Solventum Corp
Solventum Corp
21.15%
1.3%
1.3%
1.3%
1.3%
Doximity, Inc.
Doximity, Inc.
10.79%
41.18%
83.05%
-61.24%
-25.81%
Veeva Systems Inc.
Veeva Systems Inc.
15.81%
-6.25%
3.22%
-27.11%
49.13%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
4.12%
-1.61%
31.68%
43.68%
43.68%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Definitive Healthcare Corp
Definitive Healthcare Corp
NA
NA
NA
0.32
-0.5
-0.01
NA
5.51
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
47.78
47.78
2.42
0.9
0.17
0.11
NA
4.92
Veeva Systems Inc.
Veeva Systems Inc.
57.97
57.97
1.4
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
25.28
25.28
2.27
4.24
0.21
0.06
0.0
17.08
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Definitive Healthcare Corp
Definitive Healthcare Corp
Buy
$513.0M
-89.74%
NA
-156.66%
Solventum Corp
Solventum Corp
Hold
$10.8B
1.3%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$7.1B
-25.81%
47.78
32.53%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$35.3B
49.13%
57.97
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.9B
43.68%
25.28
8.1%

Insights on Definitive Healthcare Corp

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 63.48M → 63.73M (in $), with an average increase of 0.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -9.51M → -213.63M (in $), with an average decrease of 2144.5% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 83.1% return, outperforming this stock by 129.4%

Institutional Holdings

  • Advent International LP

    53.36%

  • Vanguard Group Inc

    3.98%

  • Massachusetts Financial Services Company

    3.78%

  • BlackRock Inc

    3.77%

  • Bank of America Corp

    3.52%

  • BAMCO Inc

    2.98%

Company Information

definitive healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. their product suite provides the most comprehensive and highest quality data available anywhere on over 8,100 hospitals and idns, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 acos and hies, 197,000 physician groups, 1.3 million physicians, and 750 canadian hospitals. the company’s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market. definitive healthcare is backed by spectrum equity. for more information or to trial the service, visit www.definitivehc.com.

Organization
Definitive Healthcare Corp
Employees
950
CEO
Mr. Jason Ronald Krantz
Industry
Technology

Discover More

FAQs